NCT04773964View on ClinicalTrials.gov

Study to Evaluate MET642 in Patients With NASH

PHASE2CompletedINTERVENTIONAL

Enrollment

215

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG

MET642

MET642 active treatment

DRUG

Placebo

Placebo comparator

Trial Locations (1)

78229

Pinnacle Research, San Antonio

Sponsors

Lead Sponsor

Metacrine, Inc.

All Listed Sponsors

lead

Metacrine, Inc.

INDUSTRY

NCT04773964 - Study to Evaluate MET642 in Patients With NASH | Biotech Hunter | Biotech Hunter